EUVIMEDEUVIMED entdecken
Open Access

Development of phenyl‐urea‐based small molecules that target penicillin‐binding protein 4

Vijay S Gondil, Hailey S Butman, Mikaeel Young, Danica J Walsh, Yogesh Narkhede, Michael J Zeiler, Andrew H Crow, Morgan E Carpenter, Aashay Mardikar, Roberta J Melander, Olaf Wiest, Paul M Dunman und 1 weitere

Chemical Biology & Drug Design · 2024

DOI: 10.1111/cbdd.14569 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Vijay S Gondil und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Molecular Docking Simulation, Penicillin-Binding Proteins, Staphylococcus aureus. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIAID NIH HHS, NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Staphylococcus aureus has the ability to invade cortical bone osteocyte lacuno‐canalicular networks (OLCNs) and cause osteomyelitis. It was recently established that the cell wall transpeptidase, penicillin‐binding protein 4 (PBP4), is crucial for this function, with pbp4 deletion strains unable to invade OLCNs and cause bone pathogenesis in a murine model of S . aureus osteomyelitis. Moreover, PBP4 has recently been found to modulate S . aureus resistance to β‐lactam antibiotics. As such, small molecule inhibitors of S . aureus PBP4 may represent dual functional antimicrobial agents that limit osteomyelitis and/or reverse antibiotic resistance. A high throughput screen recently revealed that the phenyl‐urea 1 targets PBP4. Herein, we describe a structure–activity relationship (SAR) study on 1. Leveraging in silico docking and modeling, a set of analogs was synthesized and assessed for PBP4 inhibitory activities. Results revealed a preliminary SAR and identified lead compounds with enhanced binding to PBP4, more potent antibiotic resistance reversal, and diminished PBP4 cell wall transpeptidase activity in comparison to 1 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsMolecular Docking SimulationPenicillin-Binding ProteinsStaphylococcus aureusAnimalsMiceBacterial ProteinsMicrobial Sensitivity TestsSmall Molecule LibrariesStructure-Activity RelationshipUrea

Stichwörter der Autor:innen

osteomyelitisPBP4methicillin‐resistant Staphylococcus aureusphenyl‐ureaβ‐lactam

Substanzen

Anti-Bacterial AgentsBacterial ProteinsPenicillin-Binding ProteinsSmall Molecule LibrariesUreaSAOUHSC_00646 protein, Staphylococcus aureus

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA.
  • Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, USA.

ORCID-Profile: Christian Melander

Förderung

  • NIH HHS
  • NIAID NIH HHS
  • NIAMS NIH HHS
  • NIDCR NIH HHS
  • National Institutes of Health

Zitieren

APA

Gondil, V. S., Butman, H. S., Young, M., Walsh, D. J., Narkhede, Y., Zeiler, M. J., Crow, A. H., Carpenter, M. E., Mardikar, A., Melander, R. J., Wiest, O., Dunman, P. M., & Melander, C. (2024). Development of phenyl‐urea‐based small molecules that target penicillin‐binding protein 4. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14569

Vancouver

Gondil VS, Butman HS, Young M, Walsh DJ, Narkhede Y, Zeiler MJ, et al. Development of phenyl‐urea‐based small molecules that target penicillin‐binding protein 4. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14569

BibTeX
@article{Gondil2024,
  author = {Gondil, Vijay S and Butman, Hailey S and Young, Mikaeel and Walsh, Danica J and Narkhede, Yogesh and Zeiler, Michael J and Crow, Andrew H and Carpenter, Morgan E and Mardikar, Aashay and Melander, Roberta J and Wiest, Olaf and Dunman, Paul M and Melander, Christian},
  title = {Development of phenyl‐urea‐based small molecules that target penicillin‐binding protein 4},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  doi = {10.1111/cbdd.14569}
}
Kostenlos starten →